Results 101 to 110 of about 1,019 (188)

New and Emerging Treatments for Generalized Pustular Psoriasis: Focus on IL-36 Receptor Inhibitors

open access: yesPharmaceutics
Generalized Pustular Psoriasis (GPP) is a rare and severe subtype of psoriasis that significantly impacts patients’ quality of life. Until recently, no specific treatment modalities were available, and treatment for GPP followed the guidelines for the ...
João Vilaça   +2 more
doaj   +1 more source

Recibokibart, an anti‐IL‐36 receptor monoclonal antibody, for treating generalized pustular psoriasis: Phase 1b trial

open access: yes
Journal of the European Academy of Dermatology and Venereology, Volume 39, Issue 6, Page e544-e546, June 2025.
Qiaoxia Qian   +21 more
wiley   +1 more source

Diagnosis, Screening and Treatment of Patients with Palmoplantar Pustulosis (PPP): A Review of Current Practices and Recommendations

open access: yesClinical, Cosmetic and Investigational Dermatology, 2020
Egídio Freitas,1 Maria Alexandra Rodrigues,1 Tiago Torres1,2 1Department of Dermatology, Centro Hospitalar e Universitário do Porto, Porto, Portugal; 2Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Porto,
Freitas E, Rodrigues MA, Torres T
doaj  

A Non-Interventional, Multicenter Study to Characterize the Socio-Demographics, Clinical Characteristics, and Management of Generalized Pustular Psoriasis Patients in Spain: IMPULSE Study [PDF]

open access: yes
Biologic treatment; Disease management; Generalized pustular psoriasisTratamiento biológico; Gestión de la enfermedad; Psoriasis pustulosa generalizadaTractament biològic; Gestió de la malaltia; Psoriasi pustulosa generalitzadaIntroduction: Generalized ...
Izu Belloso, Rosa   +5 more
core   +1 more source

Clinical Characteristics, Treatments, and Outcomes of Pyoderma Gangrenosum of the Face: A Systematic Review

open access: yes
International Wound Journal, Volume 22, Issue 4, April 2025.
Manjit Kaur   +7 more
wiley   +1 more source

New Therapies in the Biological Treatment of Psoriasis: A Review

open access: yesAllergies
Psoriasis is a chronic inflammatory autoimmune disease primarily affecting the skin and, in some cases, the joints, and is characterized by erythematous, scaling lesions. Building up the doses has been conventional, but many patients will not obtain good
Mateusz Kamil Ożóg   +4 more
doaj   +1 more source

Intralesional Spesolimab: A Novel and Effective Approach for Palmoplantar Pustulosis Treatment – A Case Report

open access: yesInternational Medical Case Reports Journal
Si-Ning Wang,* Yi-Zhou Lu,* Yujuan Zhao, Wei Cao, Rui-Li Zhang Department of Dermatology, The Second Affiliated Hospital Nanjing Medical University, Nanjing Medical University, Nanjing, People’s Republic of China*These authors contributed ...
Wang SN, Lu YZ, Zhao Y, Cao W, Zhang RL
doaj  

Diseases categorized as autoinflammatory keratinization diseases (AiKDs), and their pathologies and treatments [PDF]

open access: yes
Whole-exome and whole-genome sequencing have become widespread in approximately the last 15 years, and the predisposing factors and pathomechanisms of inflammatory keratinization diseases, which have been unknown for a long time, have gradually been ...
Akiyama, Masashi
core  

IL-36RN gene: key insights into its role in pediatric pustular psoriasis pathogenesis and treatment [PDF]

open access: yes
Pediatric pustular psoriasis (PPP) is an autoimmune skin disease that seriously affects the physical and mental health of children. The IL-36RN (Interleukin-36 Receptor Antagonist) gene plays a key role in the pathogenesis of PPP.
Changcheng Hou   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy